Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 6, 2021

A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease

  • Giovanni B. Fogazzi EMAIL logo , Giuseppe Garigali , Federico Pieruzzi , Alessandro Corbelli , Fabio Fiordaliso , Dario Consonni and Piergiorgio Messa

Abstract

Objectives

The search in the urinary sediment (U-sed) of fat particles with peculiar morphology is a simple and inexpensive tool for the diagnosis of Fabry disease (FD) nephropathy. In this study we investigated the morphology of a high number of such fat particles with the aim to obtain a morphological classification to be used for their identification.

Methods

Study of the morphology of fat particles in the U-sed of a cohort of FD patients using: bright field plus phase contrast microscopy (BF + PC), polarized light microscopy (POL), and transmission electron microscopy (TEM). Comparison of these results with those obtained for the fat particles seen in the U-sed of a control group (CG) of patients with non-FD glomerulopathies.

Results

FD: 18 U-sed from six patients (three samples/patient) were prospectively investigated and 506 fat particles identified. With BF + PC, these were classified in eight morphological categories (seven of which were confirmed by TEM), and with POL in 10 others. CG: eight U-sed from eight patients were investigated and 281 fat particles identified. These fell into four BF + PC morphological categories and into eight POL categories. While some categories were significantly more frequent in FD others were more frequent in the CG.

Conclusions

Our study demonstrates that 1. The morphology of fat particles found in the U-sed of FD patients is much wider and complex than that described so far 2. Several significant differences exist in the morphology of such fat particles between FD and CG patients.


Corresponding author: Giovanni B. Fogazzi, MD, Clinical and Research Laboratory on Urinary Sediment, U.O.C. di Nefrologia, Dialisi e Trapianto di Rene, Fondazione, IRCCS, Ca’ Granda Ospedale Maggiore Policlinico, Via della Commenda, 15, 20122 Milan, Italy, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: The authors declare that the patients whose urine sediments were requested for the investigation described in the paper have been informed that their data (without their names) would have been used for a possible research publication. All of them gave their full approval.

  5. Ethical approval: Not applicable.

References

1. Alroy, J, Sabnis, S, Kopp, JB. Renal pathology in Fabry disease. J Am Soc Nephrol 2002;13(2 Suppl):S134–8. https://doi.org/10.1097/01.asn.0000016684.07368.75.Search in Google Scholar

2. Fogo, AB, Bostad, L, Svarstad, E, Cook, WJ, Moll, S, Barbey, F, et al.. Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant 2010;25:2168–77. https://doi.org/10.1093/ndt/gfp528.Search in Google Scholar

3. Fessas, P, Wintrobe, MM, Cartwright, GE. Angiokeratoma corporis diffusum (Fabry). First American report of a rare disorder. Arch Intern Med 1955;95:469–81. https://doi.org/10.1001/archinte.1955.00250090107013.Search in Google Scholar

4. Pittelkow, RB, Kierland, RR, Montogomery, H. Angiokeratoma corporis diffusum. Arch Dermatol 1955;72:556–61. https://doi.org/10.1001/archderm.1955.03730360062007.Search in Google Scholar

5. McNary, WF, Lowenstein, LH. A morphological study of the renal lesion in angiokeratoma corporis diffusum universale (Fabry’s disease). J Urol 1965;93:641–8. https://doi.org/10.1016/s0022-5347(17)63848-5.Search in Google Scholar

6. Branton, MH, Schiffmann, R, Sabnis, SG, Murray, GJ, Quirk, JM, Altarescu, G, et al.. Natural history of Fabry renal disease. Medicine 2002;81:122–38. https://doi.org/10.1097/00005792-200203000-00003.Search in Google Scholar PubMed

7. Utsumi, K, Mitsuhashi, F, Asahi, K, Sakurazawa, M, Arii, K, Komaba, Y, et al.. Enzyme replacement therapy for Fabry disease: morphologic and histochemical changes in the urinary sediments. Clin Chim Acta 2005;360:103–7. https://doi.org/10.1016/j.cccn.2005.04.036.Search in Google Scholar PubMed

8. Selvarajah, M, Nicholls, K, Hewitson, TD, Becker, GJ. Targeted urine microscopy in Anderson-Fabry disease: a cheap, sensitive and specific diagnostic technique. Nephrol Dial Transplant 2011;26:3195–202. https://doi.org/10.1093/ndt/gfr084.Search in Google Scholar PubMed

9. Nakamichi, T, Miyazaki, M, Nakayama, K, Sato, M, Akiu, N, Sato, T, et al.. Fabry’s disease discovered with chance urinary mulberry cells: a case report. CEN Case Rep 2013;2:49–52. https://doi.org/10.1007/s13730-012-0038-x.Search in Google Scholar PubMed PubMed Central

10. Taneda, S, Honda, K, Nakajima, S, Huchinoue, S, Oda, H. Renal transplantation between siblings with unrecognized Fabry disease. Transplant Proc 2013;45:115–8. https://doi.org/10.1016/j.transproceed.2012.10.024.Search in Google Scholar PubMed

11. Honda, T, Komatsu, E, Furuse, S, Mise, N. Fabry disease diagnosed based on the detection of urinary mulberry bodies. Intern Med 2016;55:2903. https://doi.org/10.2169/internalmedicine.55.7084.Search in Google Scholar PubMed PubMed Central

12. Saito, A, Kimura, T, Takeuchi, Y, Matsuda, K, Fukami, H, Sato, H, et al.. A case of rapid progression of Fabry nephropathy with remarkable glomerulomegaly: a case report and mini literature review of weak response to enzyme replacement therapy (ERT). Ren Replace Ther 2016;2:69. https://doi.org/10.1186/s41100-016-0081-8.Search in Google Scholar

13. Shimohata, H, Ogawa, Y, Maruyama, H, Hirayama, K, Kobayashi, M. A renal variant of Fabry disease diagnosed by the presence of urinary mulberry cells. Intern Med 2016;55:3475–8. https://doi.org/10.2169/internalmedicine.55.7367.Search in Google Scholar PubMed PubMed Central

14. Shimohata, H, Maruyama, H, Miyamoto, Y, Takayasu, M, Hirayama, K, Kobayashi, M. Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease. CEN Case Rep 2017;6:148–51. https://doi.org/10.1007/s13730-017-0262-5.Search in Google Scholar PubMed PubMed Central

15. Yano, T, Takahashi, R, Yamashita, T, Nagano, N, Ishikawa, A, Sakurai, A, et al.. Detection of urinary mulberry bodies leads to diagnosis of Fabry cardiomyopathy. A simple clue in the urinary sediment. Circ Heart Fail 2017;10:4538–41. https://doi.org/10.1161/circheartfailure.117.004538.Search in Google Scholar

16. Chong, PF, Nakamura, K, Kira, R. Mulberries in the urine: a tell-tale sign of Fabry disease. J Inherit Metab Dis 2018;41:745–6. https://doi.org/10.1007/s10545-018-0155-6.Search in Google Scholar PubMed

17. Onishi, R, Kanaoka, K, Sugiura, J, Tokunaga, M, Takemoto, Y, Onoue, K, et al.. A cardiac variant of Fabry disease diagnosed with chance urinary mulberry cells. Intern Med 2018;57:3385–8. https://doi.org/10.2169/internalmedicine.1177-18.Search in Google Scholar PubMed PubMed Central

18. Matsuura, H, Asano, K. Mulberry bodies: Fabry disease. Am J Med 2018;S0002-9343:30407–8. https://doi.org/10.1016/j.amjmed.2018.04.030.Search in Google Scholar PubMed

19. Kato, Y, Ishikawa, A, Aoki, S, Sato, H, Ojima, Y, Kagaya, S, et al.. Fabry disease with pacemaker implantation as the initial event. Intern Med 2019;58:2993–3000. https://doi.org/10.2169/internalmedicine.2468-18.Search in Google Scholar PubMed PubMed Central

20. Aoyama, Y, Ushio, Y, Yokoyama, T, Taneda, S, Makabe, S, Nishida, M, et al.. Urinary mulberry cells as a biomarker of the efficacy of enzyme replacement therapy for Fabry disease. Intern Med 2020;59:971–6. https://doi.org/10.2169/internalmedicine.3813-19.Search in Google Scholar PubMed PubMed Central

21. Shimohata, H, Yamashita, M, Ohgi, K, Maruyama, H, Takayasu, M, Hirayama, K, et al.. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy. CEN Case Rep 2020;9:237–42. https://doi.org/10.1007/s13730-020-00463-z.Search in Google Scholar PubMed PubMed Central

22. Duncan, C. The renal lesion of angiokeratoma corporis diffusum (Fabry’s disease): report of three cases including some electron microscopic findings. Pathology 1970;2:9–14. https://doi.org/10.3109/00313027009077320.Search in Google Scholar PubMed

23. Katz, SM, Lyons, PJ. Urinary ultrastructural findings in Fabry disease. J Am Med Assoc 1977;237:1121–2. https://doi.org/10.1001/jama.237.11.1121.Search in Google Scholar

24. Tubbs, RR, Gephardt, GN, McMahon, J, Hall, PM, Gifford, RW. Cytoplasmic inclusions of Fabry’s disease. Arch Pathol Lab Med 1981;105:361–2.Search in Google Scholar

25. Wenk, RE, Bhagavan, BS, Francis, E. Myelin bodies in urine sediment in hemizygotes with Anderson-Fabry disease. Ultrastruct Pathol 1983;5:123–7. https://doi.org/10.3109/01913128309141831.Search in Google Scholar PubMed

26. Nagao, S, Satoh, N, Inaba, S, Iijima, S. Concentric lamellar spheres in urine from a female carrier of and patients with Fabry’s disease—with special reference to polarization and electron microscopic comparison with nephrotic syndrome. J Dermatol 1985;12:70–8. https://doi.org/10.1111/j.1346-8138.1985.tb01540.x.Search in Google Scholar PubMed

27. Praet, M, Quatacker, J, Van Loo, A, Vanholder, R, Lameire, N, Ringoir, S. Non-invasive diagnosis of Fabry’s disease by electron microscopic evaluation of urinary sediment. Nephrol Dial Transplant 1995;10:902–3. https://doi.org/10.1093/ndt/10.6.902.Search in Google Scholar

28. Murayama, Y, Uchida, M, Tojo, A, Ishimitsu, T. Electron microscopy of urinary sediments in Fabry disease. Kidney Int 2018;94:834. https://doi.org/10.1016/j.kint.2018.04.010.Search in Google Scholar PubMed

29. Levey, AS, Stevens, LA, Schmid, CH, Zhang, YL, Castro, AF, Feldman, HI, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006.Search in Google Scholar PubMed PubMed Central

30. Fogazzi, GB, Passerini, P, Bazzi, M, Bogetic, J, Barletta, L. Use of high power field in the evaluation of formed elements of urine. J Nephrol 1989;2:107–12.Search in Google Scholar

31. Blackbourn, V, Grignani, S, Fogazzi, GB. Lipiduria as seen by transmission electron microscopy. Nephrol Dial Transplant 1998;13:2682–4.10.1093/ndt/13.10.2682Search in Google Scholar PubMed

32. Fogazzi, GB. The urinary sediment. An integrated view, 3rd ed. Milano: Elsevier; 2010:71–6 pp.Search in Google Scholar

33. Haber, MH, Blomberg, D, Galagan, K, Glassy, EF, Ward, PCJ. Color atlas of the urinary sediment. An illustrated field guide based on proficiency testing. Northfield: College of American Paththologists; 2010:374–5 pp.Search in Google Scholar

34. Brunzel, NA. Fundamentals of urine and body fluid analysis, 4th ed. St Louis: Elsevier; 2018:177–9 pp.Search in Google Scholar

35. Caleffi, A, Lippi, G. Cylindruria. Clin Chem Lab Med 2015;53(Suppl):S1471–7. https://doi.org/10.1515/cclm-2015-0480.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2021-0079).


Received: 2021-01-18
Accepted: 2021-06-25
Published Online: 2021-07-06
Published in Print: 2021-10-26

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 18.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2021-0079/html
Scroll to top button